Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aspergillosis--and a misleading sensitivity result.

Literature DB >> 17617278

Aspergillosis--and a misleading sensitivity result.

Coretta van Leer-Buter¹, Robert P Takes, Konnie M Hebeda, Willem J G Melchers, Paul E Verweij.

Abstract

Mesh：

Substances：
Antifungal Agents

Year: 2007 PMID： 17617278 DOI： 10.1016/S0140-6736(07)61055-1

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

1. Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism.

Authors: Simone M T Camps; Antonius J M M Rijs; Corné H W Klaassen; Jacques F Meis; Céline M O'Gorman; Paul S Dyer; Willem J G Melchers; Paul E Verweij
Journal: J Clin Microbiol Date: 2012-06-06 Impact factor: 5.948

Review 2. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.

Authors: Simone M T Camps; Jan W M van der Linden; Yi Li; Ed J Kuijper; Jaap T van Dissel; Paul E Verweij; Willem J G Melchers
Journal: Antimicrob Agents Chemother Date: 2011-10-17 Impact factor: 5.191

3. Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling.

Authors: Eveline Snelders; Anna Karawajczyk; Gijs Schaftenaar; Paul E Verweij; Willem J G Melchers
Journal: Antimicrob Agents Chemother Date: 2010-04-12 Impact factor: 5.191

4. Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model.

Authors: Seyedmojtaba Seyedmousavi; Roger J M Brüggemann; Jacques F Meis; Willem J G Melchers; Paul E Verweij; Johan W Mouton
Journal: Antimicrob Agents Chemother Date: 2015-03-09 Impact factor: 5.191

5. Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.

Authors: Eleftheria Mavridou; Roger J M Bruggemann; Willem J G Melchers; Paul E Verweij; Johan W Mouton
Journal: Antimicrob Agents Chemother Date: 2010-08-23 Impact factor: 5.191

6. Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis.

Authors: Seyedmojtaba Seyedmousavi; Johan W Mouton; Willem J G Melchers; Paul E Verweij
Journal: Antimicrob Agents Chemother Date: 2014-12-22 Impact factor: 5.191

7. First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.

Authors: K M T Astvad; R H Jensen; T M Hassan; E G Mathiasen; G M Thomsen; U G Pedersen; M Christensen; O Hilberg; M C Arendrup
Journal: Antimicrob Agents Chemother Date: 2014-06-16 Impact factor: 5.191